Many of the pathways that SiPSiC found to be upregulated in the alveolar cells of the COVID-19 group were of therapeutic potential, including DNA repair, UPR, PI3K/AKT/MTOR signaling, ROS, and metabolic pathways. The gene discussed is AKT1; the disease is COVID-19.